Literature DB >> 19880717

Natural killer cells in chronic Lyme disease.

Raphael B Stricker, Edward E Winger.   

Abstract

Entities:  

Mesh:

Year:  2009        PMID: 19880717      PMCID: PMC2772377          DOI: 10.1128/CVI.00260-09

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


× No keyword cloud information.
  14 in total

Review 1.  A critical appraisal of "chronic Lyme disease".

Authors:  Henry M Feder; Barbara J B Johnson; Susan O'Connell; Eugene D Shapiro; Allen C Steere; Gary P Wormser; W A Agger; H Artsob; P Auwaerter; J S Dumler; J S Bakken; L K Bockenstedt; J Green; R J Dattwyler; J Munoz; R B Nadelman; I Schwartz; T Draper; E McSweegan; J J Halperin; M S Klempner; P J Krause; P Mead; M Morshed; R Porwancher; J D Radolf; R P Smith; S Sood; A Weinstein; S J Wong; L Zemel
Journal:  N Engl J Med       Date:  2007-10-04       Impact factor: 91.245

2.  Effect of electronic laboratory reporting on the burden of lyme disease surveillance--New Jersey, 2001-2006.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2008-01-18       Impact factor: 17.586

3.  Lyme borreliosis reinfection: might it be explained by a gender difference in immune response?

Authors:  Sara Jarefors; Louise Bennet; Elin You; Pia Forsberg; Christina Ekerfelt; Johan Berglund; Jan Ernerudh
Journal:  Immunology       Date:  2006-06       Impact factor: 7.397

4.  Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease.

Authors:  M S Klempner; L T Hu; J Evans; C H Schmid; G M Johnson; R P Trevino; D Norton; L Levy; D Wall; J McCall; M Kosinski; A Weinstein
Journal:  N Engl J Med       Date:  2001-07-12       Impact factor: 91.245

5.  Complement split products c3a and c4a in chronic lyme disease.

Authors:  R B Stricker; V R Savely; N C Motanya; P C Giclas
Journal:  Scand J Immunol       Date:  2009-01       Impact factor: 3.487

6.  Implications of gender in chronic Lyme disease.

Authors:  Gary P Wormser; Eugene D Shapiro
Journal:  J Womens Health (Larchmt)       Date:  2009-06       Impact factor: 2.681

7.  A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy.

Authors:  B A Fallon; J G Keilp; K M Corbera; E Petkova; C B Britton; E Dwyer; I Slavov; J Cheng; J Dobkin; D R Nelson; H A Sackeim
Journal:  Neurology       Date:  2007-10-10       Impact factor: 9.910

8.  The "ex vivo" patterns of CD2/CD7, CD57/CD11c, CD38/CD11b, CD45RA/CD45RO, and CD11a/HLA-DR expression identify acute/early and chronic/late NK-cell activation states.

Authors:  Margarida Lima; Julia Almeida; Maria dos Anjos Teixeira; Maria Luís Queirós; Benvindo Justiça; Alberto Orfão
Journal:  Blood Cells Mol Dis       Date:  2002 Mar-Apr       Impact factor: 3.039

9.  The cytolytic enzymes granyzme A, granzyme B, and perforin: expression patterns, cell distribution, and their relationship to cell maturity and bright CD57 expression.

Authors:  Pratip K Chattopadhyay; Michael R Betts; David A Price; Emma Gostick; Helen Horton; Mario Roederer; Stephen C De Rosa
Journal:  J Leukoc Biol       Date:  2008-10-10       Impact factor: 4.962

Review 10.  Dysregulation of CD8+ lymphocyte apoptosis, chronic disease, and immune regulation.

Authors:  Karen L Wood; Homer L Twigg; Andrea I Doseff
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01
View more
  2 in total

Review 1.  Diagnosis, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: A Review.

Authors:  Edgar Sanchez; Edouard Vannier; Gary P Wormser; Linden T Hu
Journal:  JAMA       Date:  2016-04-26       Impact factor: 56.272

2.  Lyme disease: the next decade.

Authors:  Raphael B Stricker; Lorraine Johnson
Journal:  Infect Drug Resist       Date:  2011-01-07       Impact factor: 4.003

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.